Signum Life Science ApS: Financial statements 2018
CVR: 36559241
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 12,039,531 and a net result of DKK 4,067,570 compared with DKK 5,500,937 the year before. That is a decrease of 3.9% compared with the year before. Equity in the 2018 report amounted to DKK 127,470,162. The solvency ratio was 83.5%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 12,039,531
- Profit/Loss
- DKK 4,067,570
- Equity
- DKK 127,470,162
- Total Assets
- DKK 152,628,992
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 12M | 4.1M | 127.5M | 21 |
| 2017 | - | 12.5M | 5.5M | 125.8M | - |
| 2016 | - | 11.4M | 4.8M | 122.5M | 16 |
| 2015 | - | 9.2M | 2.6M | 119.5M | 16 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 26, 2018, Thomas Gross Nødvig has joined the board of directors of Signum Life Science ApS.
As of November 26, 2018, Christina Dyreborg Jeppesen has joined the board of directors of Signum Life Science ApS.
As of November 26, 2018, Christoffer Dahl has joined the board of directors of Signum Life Science ApS.
As of November 26, 2018, Anders Thelborg has left the board of directors of Signum Life Science ApS.
As of November 26, 2018, Henriette Rosenquist has left the board of directors of Signum Life Science ApS.
As of November 26, 2018, Julie Enevold Brooker has left the board of directors of Signum Life Science ApS.
As of November 26, 2018, Carina Schaldemose Sørensen has left the board of directors of Signum Life Science ApS.
As of November 25, 2018, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.
As of November 25, 2018, Christina Dyreborg Jeppesen has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2017. Gross profit came to DKK 12,527,562, and the net result was DKK 5,500,937.
About Signum Life Science ApS
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.
